Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.
about
Glypican-3 Targeting Immunotoxins for the Treatment of Liver CancerStaphylococcus aureus and Lipopolysaccharide Modulate Gene Expressions of Drug Transporters in Mouse Mammary Epithelial Cells Correlation to Inflammatory BiomarkersIn Vitro Growth Inhibitory Activities of Natural Products from Irciniid Sponges against Cancer Cells: A Comparative StudyG3BP1 contributes to tumor metastasis via upregulation of Slug expression in hepatocellular carcinomaKinetic Modeling of ABCG2 Transporter Heterogeneity: A Quantitative, Single-Cell Analysis of the Side Population Assay.USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt.Integrated safety analysis of rolapitant with coadministered drugs from phase II/III trials: an assessment of CYP2D6 or BCRP inhibition by rolapitant.The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers.Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.The afatinib resistance of in vivo generated H1975 lung cancer cell clones is mediated by SRC/ERBB3/c-KIT/c-MET compensatory survival signaling.Effect of MDR1 gene polymorphisms on mortality in paraquat intoxicated patients.ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines.Glycol porphyrin derivatives and temoporfin elicit resistance to photodynamic therapy by different mechanisms.Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells.Differential impact of flavonoids on redox modulation, bioenergetics and cell signalling in normal and tumor cells: a comprehensive review.Knockout of a P-glycoprotein gene increases susceptibility to abamectin and emamectin benzoate in Spodoptera exigua.ADME-Space: a new tool for medicinal chemists to explore ADME properties.MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma.Targeting BCRP/ABCG2 by RNA interference enhances the chemotherapy sensitivity of human colon cancer side population cells.Cancer chemoprevention through dietary flavonoids: what's limiting?In vitro and in silico analysis of the vascular effects of asymmetrical N,N-bis(alkanol)amine aryl esters, novel multidrug resistance-reverting agents.Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer.The role of cancer stem cells in tumor heterogeneity and resistance to therapy.The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP.Oxidative stress management in the hair follicle: Could targeting NRF2 counter age-related hair disorders and beyond?Gibberellin derivative GA-13315 sensitizes multidrug-resistant cancer cells by antagonizing ABCB1 while agonizes ABCC1.miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer.Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression.Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer propertiesRSK1 protects P-glycoprotein/ABCB1 against ubiquitin-proteasomal degradation by downregulating the ubiquitin-conjugating enzyme E2 R1Bortezomib, carfilzomib and ixazomib do not mediate relevant transporter-based drug-drug interactionsImplications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review.SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria.Timing of chemotherapy-induced neutropenia: the prognostic factor in advanced pancreatic cancer patients treated with gemcitabine / gemcitabine-based chemotherapyCrizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents.LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1.Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells.A nanoliposome-based photoactivable drug delivery system for enhanced cancer therapy and overcoming treatment resistance.
P2860
Q28077270-88277369-19A6-4C36-BE0D-C6E81708513DQ28553833-1D9325BB-6A8C-440B-A063-B98103A96D70Q28829110-33B6289D-438D-47E4-B9BD-80FAED6D25A9Q30008811-CA803C0A-3B8D-4463-AE04-5231D1D03096Q32186144-CCA7D2B5-2850-4FD3-AB3A-C2C403F95E35Q33648632-50D0CD1F-11F2-418E-9C9C-531927225D7FQ33749075-2538F96B-FF9D-423F-95D0-B0DE7B94B744Q33809605-5FB96256-FDB5-4ECD-B668-B528BBBCC3DEQ33834080-168F03F8-F157-426C-92D9-088709819632Q33889185-04C2FF3A-165C-4C17-98C7-7D87CB3CE0E8Q37190128-1820FD66-FDEC-4349-AC76-9AB00979AEA1Q37193122-9C06B1AA-51F2-4683-A0D4-B70D54197CF3Q37688480-984289EA-40C6-44B5-B3EA-CD1ED46B15B6Q37704800-2483FE63-4B16-4C6B-8C51-FEA06FA759E5Q38602104-457B097E-0D56-486E-90C2-04A7A5CA2706Q38616035-8E40B2AC-BCD6-42C5-908B-D11AC8CE085EQ38655471-B724161D-7CA1-4D5E-9F7B-7D2B05AFE1C6Q38661488-2510558D-BD94-4F7E-BBA9-8E5CF098502BQ38706022-8FE1FBB0-36A6-4564-BD96-FE38E25194FBQ38708140-074D828F-E37B-42A3-BE87-22CD13C541A5Q38718844-0EFBB97B-DFC5-4169-A7E1-2284212AE6E1Q38761314-88190F5A-F455-4B90-BA44-3897D0BDC3FBQ38813380-F7AFE72D-04C5-4815-8ED3-C7C5CD1DC043Q39031410-52B4AC59-01C6-4E95-B129-09B122929F47Q39196784-072C3565-C970-4421-BC8E-283463103FEAQ39233839-9E407306-B87B-4CDF-826C-D4C10EA9AE1BQ39420496-B9B93A63-F849-45F7-BB76-5BD59FE2E694Q39782004-9DA6489C-349B-40D7-BE03-BC4E5AF30F6AQ41082524-556B24C4-C263-4FAA-AF38-DCF29AED8699Q41481123-E0E3397A-46F9-40FB-A709-687521D3F1ABQ41580211-E36099B8-5613-4437-85B1-E540110203EDQ41587932-BEBE0018-8FFB-4BB5-B799-30D302E9DE50Q41620033-F0C9E484-C0E5-4377-901B-8D54C3DF3260Q41660826-FBBC57D8-020F-41C5-889C-4DD236FDF384Q41911842-91F061C3-38A1-41E8-99EC-C37188D6EFDEQ42371672-01798598-48F6-4C36-B9BB-5E0CF4FAC7C6Q42373819-44ADCBAB-8573-4312-A48F-018CCC839FF3Q42654010-5C5264E8-0F0D-4C9C-9087-5712CAC00516Q42700754-8DD19045-6450-49E9-AF1C-87B8BB54D243Q47098173-1692F143-3552-424D-AF3F-5AF259326551
P2860
Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Mammalian drug efflux transpor ...... : A review of the past decade.
@en
type
label
Mammalian drug efflux transpor ...... : A review of the past decade.
@en
prefLabel
Mammalian drug efflux transpor ...... : A review of the past decade.
@en
P2093
P1433
P1476
Mammalian drug efflux transpor ...... : A review of the past decade.
@en
P2093
Cheng Huang
Ling Jiang
Mingying Deng
Pengli Zhu
Tianlu Shi
Tingting Hu
Zhaolin Chen
P304
P356
10.1016/J.CANLET.2015.10.010
P407
P577
2015-10-20T00:00:00Z